These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4784929)

  • 1. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration.
    Crapper DR; Krishnan SS; Dalton AJ
    Trans Am Neurol Assoc; 1973; 98():17-20. PubMed ID: 4784929
    [No Abstract]   [Full Text] [Related]  

  • 2. The association of aluminum Alzheimer's disease, and neurofibrillary tangles.
    Perl DP; Good PF
    J Neural Transm Suppl; 1987; 24():205-11. PubMed ID: 3316495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration.
    Crapper DR; Krishnan SS; Dalton AJ
    Science; 1973 May; 180(4085):511-3. PubMed ID: 4735595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity.
    Scholtz CL; Swash M; Gray A; Kogeorgos J; Marsh F
    Clin Neuropathol; 1987; 6(3):93-7. PubMed ID: 3608291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminum levels in brain in Alzheimer's disease.
    Trapp GA; Miner GD; Zimmerman RL; Mastri AR; Heston LL
    Biol Psychiatry; 1978 Dec; 13(6):709-18. PubMed ID: 737258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibrillary pathology.
    Wiśniewski H; Terry RD; Hirano A
    J Neuropathol Exp Neurol; 1970 Apr; 29(2):163-76. PubMed ID: 5435819
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of immunocytochemical, neurochemical, and behavioral studies in aluminum-induced neurofilamentous degeneration.
    Pendlebury WW; Beal MF; Kowall NW; Solomon PR
    J Neural Transm Suppl; 1987; 24():213-7. PubMed ID: 3479524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibrillary axonal pathology in aluminum intoxication.
    Troncoso JC; Price DL; Griffin JW; Parhad IM
    Ann Neurol; 1982 Sep; 12(3):278-83. PubMed ID: 7137964
    [No Abstract]   [Full Text] [Related]  

  • 9. Aluminum: a possible neurotoxic agent in Alzheimer's disease.
    Crapper DR; Krishnan SS; De Boni U; Tomko GJ
    Trans Am Neurol Assoc; 1975; 100():154-6. PubMed ID: 1241624
    [No Abstract]   [Full Text] [Related]  

  • 10. Aluminum and Alzheimer's disease.
    McLachlan DR
    Neurobiol Aging; 1986; 7(6):525-32. PubMed ID: 3550508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminum: a role in degenerative brain disease associated with neurofibrillary degeneration.
    McLachlan DR; Van Berkum MF
    Prog Brain Res; 1986; 70():399-410. PubMed ID: 3554357
    [No Abstract]   [Full Text] [Related]  

  • 12. Aluminum neurotoxicity and Alzheimer's disease.
    Still CN
    J S C Med Assoc; 1994 Nov; 90(11):560-4. PubMed ID: 7853860
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations in short-term retention, conditioned avoidance response acquisition and motivation following aluminum induced neurofibrillary degeneration.
    Crapper DR; Dalton AJ
    Physiol Behav; 1973 May; 10(5):925-33. PubMed ID: 4577243
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW; Lee VM; Trojanowski JQ
    Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum and the central nervous system.
    Wisniewski HM; Sturman JA; Shek JW; Iqbal K
    J Environ Pathol Toxicol Oncol; 1985; 6(1):1-8. PubMed ID: 2415697
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurofibrillary degeneration induced by systemic aluminum.
    Boni UD; Otvos A; Scott JW; Crapper DR
    Acta Neuropathol; 1976 Aug; 35(4):285-94. PubMed ID: 961381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminum induced neurofibrillary degeneration, brain electrical activity and alterations in acquisition and retention.
    Crapper DR; Dalton AJ
    Physiol Behav; 1973 May; 10(5):935-45. PubMed ID: 4736728
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
    Savory J; Huang Y; Wills MR; Herman MM
    Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.
    MacDonald AB
    Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging.
    Markesbery WR; Ehmann WD; Hossain TI; Alauddin M; Goodin DT
    Ann Neurol; 1981 Dec; 10(6):511-6. PubMed ID: 7325600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.